In this special event, learn of the processes that healthcare companies need to follow to attain approvals and how the trial phases work. In addition, gain valuable insights on whats moving the sector, as well as some of the most notable entities within the space.
Join guest speakers from ASX healthcare companies, including:
- Recce Pharmaceuticals (ASX:RCE): Chief Scientific Officer, Michele Dilizia
- BlinkLab (ASX:BB1): Chairman, Brian Leedman
- Race Oncology (ASX:RAC): CEO, Daniel Tillett
- Bioshares: Editor, Mark Pachacz
Attendees will also have the opportunity to take part in a liveQ+A with panel participants.
In this special event, learn of the processes that healthcare...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
-0.013(3.23%) |
Mkt cap ! $108.4M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 37.5¢ | $34.76K | 91.29K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9853 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 48258 | 1 |
View Market Depth
| Last trade - 15.44pm 01/08/2025 (20 minute delay) ? |
| RCE (ASX) Chart |